42
Views
24
CrossRef citations to date
0
Altmetric
Original Research

miR-125a-5p inhibits colorectal cancer cell epithelial–mesenchymal transition, invasion and migration by targeting TAZ

, , , , , & show all
Pages 3481-3489 | Published online: 07 May 2019

References

  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386. doi:10.1002/ijc.2921025220842
  • Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):i1–i9. doi:10.1093/annonc/mdu061.124764359
  • Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104–117. doi:10.3322/caac.2122024639052
  • Cao H, Xu E, Liu H, Wan L, Lai M. Epithelial-mesenchymal transition in colorectal cancer metastasis: a system review. Pathol Res Pract. 2015;211:557–569. doi:10.1016/j.prp.2015.05.01026092594
  • Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1–12. doi:10.1016/j.ydbio.2006.08.02816989803
  • Bhartiya D, Scaria V. Genomic variations in non-coding RNAs: structure, function and regulation. Genomics. 2016;107:59–68. doi:10.1016/j.ygeno.2016.01.00526790601
  • Kim JK, Noh JH, Jung KH, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 2013;57:1055–1067. doi:10.1002/hep.2610123079745
  • Sun Y, Liu X, Zhang Q, et al. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b. Tumour Biol. 2016;37:4963–4972. doi:10.1007/s13277-015-4178-426531722
  • Wang G, Mao W, Zheng S, Ye J. Epidermal growth factor receptor-regulated miR-125a-5p–a metastatic inhibitor of lung cancer. FEBS J. 2009;276:5571–5578. doi:10.1111/j.1742-4658.2009.07238.x19702827
  • Tong Z, Liu N, Lin L, Guo X, Yang D, Zhang Q. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. Biomed Pharmacother. 2015;75:129–136. doi:10.1016/j.biopha.2015.07.03626297542
  • Yuan J, Xiao G, Peng G, et al. MiRNA-125a-5p inhibits glioblastoma cell proliferation and promotes cell differentiation by targeting TAZ. Biochem Biophys Res Commun. 2015;457:171–176. doi:10.1016/j.bbrc.2014.12.07825542152
  • Chan SW, Lim CJ, Guo K, et al. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 2008;68:2592–2598. doi:10.1158/0008-5472.CAN-07-269618413727
  • Malik SA, Khan MS, Dar M, Hussain MU, Mudassar S. TAZ is an independent prognostic factor in non-small cell lung carcinoma: elucidation at protein level. Cancer Biomark. 2017;18:389–395. doi:10.3233/CBM-16026328128737
  • Yang R, Wu Y, Zou J, et al. The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway. Oncotarget. 2016;7:36255–36265. doi:10.18632/oncotarget.919927167112
  • Xie D, Cui J, Xia T, et al. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression. Oncotarget. 2015;6:35949–35963. doi:10.18632/oncotarget.v6i3426416426
  • Yuen H-F, McCrudden CM, Huang Y-H, et al. TAZ expression as a prognostic indicator in colorectal cancer. PLoS One. 2013;8:e54211. doi:10.1371/journal.pone.005421123372686
  • Xu P, Wang J, Sun B, Xiao Z. Integrated analysis of miRNA and mRNA expression data identifies multiple miRNAs regulatory networks for the tumorigenesis of colorectal cancer. Gene. 2018;659:44–51. doi:10.1016/j.gene.2018.03.050
  • Cao Y, Tan S, Tu Y, et al. MicroRNA-125a-5p inhibits invasion and invasion and migration of gastric cancer cells by targeting BRMS1 expression. Oncol Lett. 2018;15:5119–5130. doi:10.3892/ol.2018.798329552146
  • Yan L, Yu M-C, Gao G-L, et al. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1. J Cell Biochem. 2018;119(11):8773–8783. doi:10.1002/jcb.2712430076753
  • Yang X, Qiu J, Kang H, Wang Y, Qian J. miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA. Cancer Manag Res. 2018;10:5839–5853. doi:10.2147/CMAR.S16199030510452
  • Pan D. The hippo signaling pathway in development and cancer. Dev Cell. 2010;19:491–505. doi:10.1016/j.devcel.2010.09.01120951342
  • Hong J-H, Hwang ES, McManus MT, et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005;309:1074–1078. doi:10.1126/science.111095516099986
  • Wang Q, Xu Z, An Q, et al. TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells. Mol Med Rep. 2015;11:982–988. doi:10.3892/mmr.2014.281825354978